Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials

ConclusionBempedoic acid reduces the risk of MACE and all-cause mortality, lowers serum total cholesterol and LDL-C levels, and has a favorable safety profile.Trial registration ClinicalTrial.gov Identifier: CRD42023412837.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research